Search results
Results from the WOW.Com Content Network
In the mid-20th century, researchers theorized that depression was caused by a chemical imbalance in neurotransmitters in the brain, a theory based on observations made in the 1950s of the effects of reserpine and isoniazid in altering monoamine neurotransmitter levels and affecting depressive symptoms. [32] During the 1960s and 70s, manic ...
The first diagnostic distinction to be made between manic-depression involving psychotic states, and that which does not involve psychosis, came from Carl Jung in 1903. [16] [17] Jung's distinction is today referred to in the DSM-IV as that between 'bipolar I' (mania involving possible psychotic episodes) and 'bipolar II' (hypomania without ...
Researchers theorized that depression was caused by a chemical imbalance in neurotransmitters in the brain, a theory based on observations made in the 1950s of the effects of reserpine and isoniazid in altering monoamine neurotransmitter levels and affecting depressive symptoms. [90] During the 1960s and 70s, manic-depression came to refer to ...
Since anxiety, depression, and all disorders of the mind are still largely stigmatized among men, my first coping tactic was denial, lest I appeared weak and vulnerable among my peers.
For premium support please call: 800-290-4726 more ways to reach us
In early 20th century, lobotomy was introduced until the mid-1950s. In 1927 insulin coma therapy was introduced and used until 1960. Physicians deliberately put the patient into a low blood sugar coma because they thought that large fluctuations in insulin levels could alter the function of the brain.
1960 – R. D. Laing published The Divided Self which saw mental illness as an expression or communication of the individual and so represented valid descriptions of lived experience or reality rather than as symptoms of some separate or underlying disorder.
The psychopharmacology revolution covers the introduction of various psychiatric drugs into clinical practice as well as their continued development. Although not exclusively limited to the 1950s period, the literature tends to suggest that this decade was a particularly fruitful time for CNS drug discovery and it has been referred to as a "golden era".